STT three-lens brief
Evidence-based stock research on STT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 15.2pp over 30 days. · Trading at 92% of its 52-week range — near the top of the band.
- Trading at 92% of its 52-week range — near the top of the band.
- RSI at 75 — technically overbought.
- Outperforming SPY by 15.2pp over 30 days.
STT closed at $150.74 (-0.34%) as of 2026-04-25. Market cap: $42.02B. P/E (trailing) 15.3. Positives: outperforming SPY by 15.2pp over 30 days.. Concerns: trading at 92% of its 52-week range — near the top of the band.; rSI at 75 — technically overbought.. Last quarter: Revenue $3.80B, net income $705.00M.
Why three lenses on STT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine STTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/STT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath STT brief"></iframe>